Patents by Inventor Ting Zhang

Ting Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190241994
    Abstract: The invention relates to a method for preparing titanium alloys based on aluminothermic self-propagating gradient reduction and slag-washing refining, and belongs to the technical field of titanium-aluminum alloys. The method comprises the following steps of pre-treating raw materials, weighing the raw materials in the mass ratio of rutile or high-titanium slags or titanium dioxide to aluminum powder to V2O5 powder to CaO to KClO3 being 1.0:(0.60-0.24):(0.042-0.048):(0.12-0.26):(0.22-0.30), performing an aluminothermic self-propagating reaction in a gradient feeding manner to obtain high-temperature melt, performing a gradient reduction melting, performing heat insulation and separating the melt after the feeding is completed, then adding CaF2—CaO—TiO2—V2O5 based refining slags into the high-temperature melt, performing slag washing refining, and finally removing slags to obtain titanium alloys.
    Type: Application
    Filed: May 21, 2018
    Publication date: August 8, 2019
    Inventors: Zhi he DOU, Ting an ZHANG, Yan LIU, Guo zhi LV, Qiu yue ZHAO, Li ping NIU, Da xue FU, Wei guang ZHANG
  • Publication number: 20190233406
    Abstract: Disclosed are compounds of Formula A, or a salt thereof: wherein R1, R2, and E are defined herein, which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain disorders, cough, and itch using the same.
    Type: Application
    Filed: January 11, 2019
    Publication date: August 1, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Thomas J. Greshock, James Mulhearn, Junying Zheng, Ronald M. Kim, Ting Zhang, Anthony J. Roecker, Walter Won, Philippe Nantermet, Rajan Anand, Gang Zhou, Deping Wang, Liangqin Guo
  • Publication number: 20190230746
    Abstract: A method for ironmaking by smelting reduction in a stir-generated vortex includes: (1) placing a pig iron in an induction furnace, and then heating the pig iron to a molten state to form a molten iron, and maintaining the molten iron to be greater than or equal to 1450° C.; (2) stirring a center of the molten iron to form a vortex with a height-to-diameter ratio of 0.5-2.5, and continuously performing stirring; (3) mixing and grinding on an iron-containing mineral, a reducing agent and a slag-forming agent in a mass ratio of 1:(0.1-0.15):(0.25-0.4) to obtain a powder mixture, spraying and blowing the powder mixture to a center of the vortex, performing a reduction reaction, and stopping the stirring after the molten iron and molten slags are obtained, wherein a waste gas is produced; and (4) discharging the molten iron and the molten slags respectively, and exhausting a treated waste gas.
    Type: Application
    Filed: April 28, 2017
    Publication date: July 25, 2019
    Inventors: Ting an ZHANG, Yan LIU, Zhi he DOU, Zi mu ZHANG, Guo zhi LV
  • Patent number: 10351558
    Abstract: The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds are selective Factor IXa inhibitors.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: July 16, 2019
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Dongfang Meng, Hong Li, Meng Yang, Manuel de Lera Ruiz, Sunita V. Dewnani, Tianying Jian, Dann L. Parker, Jr., Ting Zhang, Louis-Charles Campeau, Harold B. Wood, Jiayi Xu, Richard Berger, Jane Yang Wu, Robert K. Orr, Shawn P. Walsh, Bart Harper
  • Publication number: 20190179417
    Abstract: The embodiment of the present application discloses a 3D interaction method, device, computer equipment and storage medium. The method comprises the steps of acquiring motion trail data of a gesture; identifying hand joint position information of the gesture based on the motion trail data; identifying a trigger as a corresponding trigger gesture to realize an interaction operation in an interactive interface based on stay or movement of the hand joint position information within a preset time, wherein the gesture is within an acquisition scope of non-contact gesture control equipment. Thus, the usability of non-contact gesture recognition is improved and the misjudgment rate is reduced with higher operational fluency, better compatibility and improved user experience.
    Type: Application
    Filed: April 18, 2018
    Publication date: June 13, 2019
    Inventors: Yantao Yang, Ting Zhang, Junqing Fang, Ting Cao
  • Publication number: 20190155215
    Abstract: The embodiment of the present application discloses a method, device, system and storage medium for displaying a holographic portrait in real time, applicable to reducing latency and achieving real-time display. A method in the application embodiment comprises: acquiring portrait data of a figure through somatosensory equipment; acquiring portrait data within a preset range as effective portrait data; blurring and storing the effective portrait data; sending the blurred effective portrait data to holographic display equipment frame by frame based on a first-in first-out principle, so as to display the effective portrait data of the figure on holographic projection of the holographic display equipment in real time, achieve real-time display of the holographic portrait, have a lower latency and improve user experience.
    Type: Application
    Filed: April 18, 2018
    Publication date: May 23, 2019
    Inventors: Yantao Yang, Ting Zhang, Junqing Fang, Ting Cao
  • Patent number: 10295401
    Abstract: A flexible conductive diaphragm comprises at least one conductive film, and the conductive film comprises a flexible support layer (1), a flexible sensitive layer (2) overlapped on the flexible support layer (1), a flexible conductive layer (3) overlapped on the flexible sensitive layer (2), and an electrode (4) electrically connected with the flexible conductive layer (3). A method for preparing the flexible conductive diaphragm and a flexible vibration sensor based on the flexible conductive diaphragm are provided. With the combination of the techniques such as the flexible material, the nano-material and the arrayed micro-structure, the flexible vibration sensor has the characteristics of high sensitivity, low preparation cost, light weight, small thickness, small size, and being foldable and flexible, and can be applied in wearable or adherable electronic devices.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: May 21, 2019
    Assignee: SUZHOU INSTITUTE OF NANO-TECH AND NANO-BIONICS (SINANO), CHINESE ACADEMY OF SCIENCES
    Inventors: Ting Zhang, Yang Gu
  • Patent number: 10278994
    Abstract: The present invention discloses a method for the preparation of skipjack tuna extract having hypouricemic effect and the use thereof, which is simple in processing operations, low in production cost, and is free from pollution. The prepared skipjack tuna extract has a potent hypouricemic effect, and has a significant therapeutic effect on hyperuricemia, with no toxic and side effects. The method in an example of the present invention comprises: pretreating skipjack tuna to obtain a skipjack tuna slurry; enzymolysing the skipjack tuna slurry to obtain a crude enzymolysis liquid; removing fishy smell and bitter taste, removing impurities by activated charcoal, and filtering to obtain a refinded enzymolysis liquid; concentrating under vacuum and spray-drying to obtain the skipjack tuna extract. The present invention further discloses use of the skipjack tuna extract in health care products or food products.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: May 7, 2019
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Bin Shi, Xiaolei Guo, Chung Wah Ma, Ting Zhang, Wei Zhang
  • Patent number: 10276045
    Abstract: A computer-implemented method includes receiving a data stream, the data stream including one or more driving factors. The computer-implemented method further includes comparing the one or more driving factors to one or more known driving factors to identify a driving scenario. The computer-implemented method further includes monitoring the driving scenario for a risk. Monitoring the driving scenario for a risk further includes detecting the risk. The computer-implemented method further includes generating an intervention, wherein the intervention is generated based on detecting the risk for the driving scenario. A corresponding computer system and computer program product are also disclosed.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: April 30, 2019
    Assignee: International Business Machines Corporation
    Inventors: Ci-Wei Lan, Wen Zhu Liu, Dong Ni, Yiping Qu, Yu Wei Sun, Li Yue, Jie Xu, Ting Ting Zhang
  • Publication number: 20190104427
    Abstract: Systems and methods are described herein for analyzing the performance of a communications network (e.g., a mobile telecommunications network) using customer-centric and/or subscriber-centric data and information. In some embodiments, the systems and method may determine key performance indicators for a communications network by accessing call detail records from multiple communications network sources, generating a database of one or more customer stats table (CSTs) based on the accessed call records, wherein the CSTs include records for each individual customers of the communications network, and determining one or more key performance indicators (KPIs) for the overall network based on the records stored by the one or more customer stats tables.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 4, 2019
    Inventors: Le Roy Munar, Doris Ho, Ting Zhang
  • Publication number: 20190092738
    Abstract: Disclosed are compounds of Formula A-1, or a salt thereof: Formula A-1, where J, K, Q and R1 are as defined herein, which compounds have properties for inhibiting sodium ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A-1 or their salts, and methods of treating pain (e.g. chronic pain), or cough or itch disorders using the same.
    Type: Application
    Filed: March 17, 2017
    Publication date: March 28, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Anthony J. Roecker, Mark E. Layton, Thomas J. Greshock, Joseph E. Pero, Michael J. Kelly, III, Ting Zhang
  • Patent number: 10221167
    Abstract: Disclosed are compounds of Formula A, or a salt thereof: wherein R1, R2, and E are defined herein, which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain disorders, cough, and itch using the same.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: March 5, 2019
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Thomas J. Greshock, James Mulhearn, Junying Zheng, Ronald M. Kim, Ting Zhang, Anthony J. Roecker, Walter Won, Philippe Nantermet, Rajan Anand, Gang Zhou, Deping Wang, Liangqin Guo
  • Publication number: 20190046498
    Abstract: Disclosed is a method of inhibiting growth of a melanoma cancer cell. The method includes contacting the melanoma cancer cell with an effective amount of a composition and the composition contains polymethoxyflavone. The polymethoxyflavone can be applied in an amount of 0.1 ?mol/L-1000 ?mol/L. A method of treating a subject having melanoma with the above discussed composition is also included.
    Type: Application
    Filed: August 11, 2017
    Publication date: February 14, 2019
    Inventors: Shiming LI, Tao Long, Guliang Yang, Xiaojian Lv, Yin Xu, Ting Zhang
  • Publication number: 20190031724
    Abstract: Provided is a papillomavirus chimeric protein, the skeleton thereof being a papillomavirus L1 protein or a mutant thereof, at least one human papillomavirus 33-type L2 protein or mutant polypeptide thereof being embedded on the skeleton. The present papillomavirus chimeric protein can be used for preparing a vaccine for preventing papillomavirus infections and infection induced disease.
    Type: Application
    Filed: March 2, 2017
    Publication date: January 31, 2019
    Inventors: Xuemei XU, Xue CHEN, Ting ZHANG, Zhirong WANG, Hongyang LIU, Shuo WANG, Meili HU
  • Patent number: 10189819
    Abstract: The present invention provides a compound of Formula I, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds are selective Factor IXa inhibitors.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: January 29, 2019
    Assignees: Merck Sharp & Dohme, Corp., Mochida Paraceuticals Co., Ltd.
    Inventors: Ting Zhang, Yi-Heng Chen, Liangqin Guo, Alan Hruza, Tianying Jian, Bing Li, Dongfang Meng, Dann L. Parker, Edward C. Sherer, Harold B. Wood, Isao Sakurada
  • Publication number: 20180362518
    Abstract: Disclosed are compounds of Formula A, or a salt thereof, where Q, X, R1 and R2 are as defined herein, which compounds have properties for inhibiting Na 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain (acute, post-operative, neuropathic), or cough or itch disorders using the same.
    Type: Application
    Filed: December 15, 2016
    Publication date: December 20, 2018
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Thomas J. Greshock, James Mulhearn, Liangqin Guo, Ting Zhang, Deping Wang, Ronald M. Kim, Mark E. Layton, Michael J. Kelly, III, Rajan Anand, Philippe Nantermet, Tianying Jian, Anthony J. Roecker, Walter Won, Gang Zhou
  • Publication number: 20180336251
    Abstract: An embodiment of the present invention discloses a travel assisting method, including: extracting trip information from content saved in a terminal and saving the extracted trip information in a trip list; selecting the trip information from the trip list, automatically connecting to a preset network address or a preset server address, and searching by using part or all of content of each piece of the selected trip information as a key word, so as to obtain assisting information corresponding to the trip information; and generating prompting information. Correspondingly, an embodiment of the present invention further discloses a terminal. The present invention enables the terminal to automatically provide effective reference information for a user according to a trip of the user, solving the problem that an operation is troublesome and time-consuming when the user obtains trip-related assisting information by using the terminal.
    Type: Application
    Filed: June 7, 2018
    Publication date: November 22, 2018
    Applicant: Huawei Device (Dongguan) Co., Ltd.
    Inventors: Ting ZHANG, Hongjun Wang
  • Publication number: 20180312508
    Abstract: The present invention relates to a compound of formula I, a stereoisomer, a prodrug, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, and a process for preparing the same, a pharmaceutical composition comprising the same, and use of the compound in the preparation of medicine preventing and treating tumors, wherein the substituents are as defined in the specification.
    Type: Application
    Filed: April 25, 2016
    Publication date: November 1, 2018
    Applicant: Xiamen University
    Inventors: Xianming DENG, Zhongji ZHUANG, Zhou DENG, Xuaixing HUANG, Yan LIU, Ting ZHANG, Wei HUANG, Qingyan XU, Zhiyu HU
  • Patent number: 10108501
    Abstract: The invention discloses a terminal backup and recovery method. When in backup, a user interface is provided at a terminal side first, so as to provide, according to a preset display policy, different backup categories for a user to select, wherein the different backup categories comprise different backup objects. Then, according to a backup category and object selected by the user, at the terminal side, a terminal file corresponding to the backup object is backed up at a cloud server according to a preset backup policy. When in recovery, according to a recovery category and object selected by the user, a file already backed up by the terminal/user and corresponding to the backup object is determined at the cloud server, and according to a preset recovery policy, corresponding recovery is executed at the terminal side by using the backed-up file. The invention provides classified backup and recovery, and increases the speed of backup and recovery.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: October 23, 2018
    Assignee: Beijing Qihoo Technology Company Limited
    Inventors: Zhizhou Zhang, Ting Zhang, Zhaohe Geng, Junliang Song
  • Patent number: D834559
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: November 27, 2018
    Assignee: Creative Technology Ltd
    Inventor: Ting Ting Zhang